Struthanthus concinnus
Struthanthus concinnus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Struthanthus concinnus is a botanical species recognized for its diverse range of bioactive chemical constituents. Research into this plant has identified significant compounds, including steroids, terpenoids, and obtusifoliol. These chemical properties are often studied through various preparations such as extracts, fractions, hexane extracts, and isolated compounds. Scientific investigations have specifically explored the potential of these substances in addressing medical conditions like tuberculosis. Consequently, understanding its chemical profile is essential for advancing its pharmacological applications.
- Synonyms
- Struthanthus Concinnus Var. Centralis · Loranthus Concinnus
- Common names
- Not available
- Family
- Loranthaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Struthanthus concinnus is a botanical subject characterized by several distinct taxonomic designations. Within scientific literature, it is frequently identified by its synonym, Loranthus concinnus. The plant's complex classification also includes the recognized variety known as Struthanthus concinnus var. centralis. These varying names highlight the intricate ways researchers categorize different forms of the species. Understanding these relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Struthanthus concinnus belongs to the vast kingdom Plantae, representing a unique branch of the living world. Within this kingdom, it is classified under the class Equisetopsida and the specific order Santalales. As a member of the genus Struthanthus, it displays specialized characteristics unique to its lineage. Furthermore, this plant is a distinct representative of the family Loranthaceae. Through these scientific classifications, we can better understand its precise place within the complex botanical hierarchy.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Santalales |
| Family | Loranthaceae |
| Genus | Struthanthus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Struthanthus concinnus is a botanical species primarily distributed throughout the diverse landscapes of Southern America. Its presence is particularly widespread across Brazil, where it thrives in the Northeast, Southeast, and West-Central regions. This plant also makes its mark in the northern reaches of Brazil, showcasing a broad adaptability to varied climates. Beyond the Brazilian borders, its habitat extends into Northern South America, specifically within Guyana. Such a wide geographical range highlights the significant ecological importance of this species across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Struthanthus concinnus is characterized by its distinct growth form as an herb. This plant is entirely self-supporting, maintaining its structure without the need for external aid.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Struthanthus concinnus, a species of mistletoe commonly used in traditional medicine, has shown significant promise in the search for new antimycobacterial agents. Through bioassay-guided fractionation of hexane extracts, researchers successfully identified several key bioactive compounds within the plant. Specifically, the chemical analysis revealed that the species contains both steroids and terpenoids. Furthermore, the isolation process identified the presence of obtusifoliol, a compound that demonstrated activity against Mycobacterium tuberculosis strains. These findings highlight the medicinal potential of the plant and provide scientific validation for its traditional use in treating lung ailments.
Conditions
Struthanthus concinnus is a species of mistletoe traditionally utilized in the open-air markets of Rio de Janeiro, Brazil, to treat tuberculosis. This plant holds a high Salience Index among medicinal species specifically selected by herbalists for addressing lung-related ailments. Scientific investigation through bioassay-guided fractionation has identified steroids and terpenoids within its hexane extracts that possess antimycobacterial activity. Testing against both susceptible and rifampicin-resistant strains of Mycobacterium tuberculosis confirmed the effectiveness of its isolated compounds. These findings provide a scientific basis for the traditional use of Struthanthus concinnus in managing tuberculosis symptoms.
Preparations
Struthanthus concinnus is prepared as extracts to be tested for antimycobacterial activity against various Mycobacterium tuberculosis strains. The plant is also prepared as fractions through a bioassay-guided fractionation process. Specifically, the species is prepared as hexane extracts to facilitate the identification of active principles. These chemical processes further allow the plant to be prepared as isolated compounds, such as steroids and terpenoids. Through these different preparation methods, researchers can determine the minimum inhibitory concentrations of the plant's constituents.